Lexicon Pharmaceuticals (United States)

About

In recent decades, authors affiliated with Lexicon Pharmaceuticals (United States) have published 494 papers, which have received a total of 25.3k indexed citations. Scholars at this organization have produced 188 papers in Molecular Biology, 94 papers in Endocrinology, Diabetes and Metabolism and 56 papers in Surgery on the topics of Diabetes Treatment and Management (62 papers), Pancreatic function and diabetes (44 papers) and Diabetes Management and Research (34 papers). Their work is cited by papers focused on Molecular Biology (11.5k citations), Endocrinology, Diabetes and Metabolism (5.3k citations) and Surgery (3.4k citations). Authors at Lexicon Pharmaceuticals (United States) collaborate with scholars in United States, Germany and United Kingdom and have published in prestigious journals including Nature, New England Journal of Medicine and Cell. Some of Lexicon Pharmaceuticals (United States)'s most productive authors include Brian Zambrowicz, Arthur Sands, Kenneth A. Platt, Peter Vogel, Pablo Lapuerta, Taghi M. Khoshgoftaar, Flavio Villanustre, Randall Wald, Edin Muharemagic and Maryam M. Najafabadi.

In The Last Decade

Lexicon Pharmaceuticals (United States)

458 papers receiving 25.2k citations

Fields of papers published by authors at Lexicon Pharmaceuticals (United States)

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Lexicon Pharmaceuticals (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Lexicon Pharmaceuticals (United States) at the time of their publication.

Countries citing scholars working at Lexicon Pharmaceuticals (United States)

Since Specialization

Citations

This map shows the geographic impact of research produced by authors working at Lexicon Pharmaceuticals (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Lexicon Pharmaceuticals (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lexicon Pharmaceuticals (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Breakdown of academic impact, for scholars at Agence internationale de l'énergie Breakdown of academic impact, for scholars at Heidelberg Academy of Sciences and Humanities Breakdown of academic impact, for scholars at Immunologie et Neurogénétique Expérimentales et Moléculaires Breakdown of academic impact, for scholars at California Institute for Biomedical Research Breakdown of academic impact, for scholars at Cosmos Corporation (United States) Breakdown of academic impact, for scholars at Abdul Latif Jameel Poverty Action Lab Breakdown of academic impact, for scholars at Black AIDS Institute Breakdown of academic impact, for scholars at Nanosystems Initiative Munich